Current Oncology is pleased to introduce a new section entitled “Medical Economics”. Dr. Natasha Leighl and Dr. Nicole Mittmann, co-chairs of the Comm


Current Oncology is pleased to introduce a new section entitled “Medical Economics”. Dr. Natasha Leighl and Dr. Nicole Mittmann, co-chairs of the Committee on Economic Analysis at the NCIC-Clinical Trials Group, co-edit this new section for the journal. Given the current health care environment of fiscal responsibility, the implementation of pay for performance indicators and health technology assessment frameworks for new technologies, there is a need for research to consider economic evaluations.

This section will provide the journal’s unique readership with a forum to discuss topical, compelling and important oncology health economic issues from national and international perspectives. We welcome submissions related to policy decision-making, economic evaluations, burden of illness studies, health preference evaluations and methodological research. The link for submissions is

We would also like to take the opportunity to invite you to recommend information to include in our newsletter. We welcome information that is of importance to the Oncology community such as events, oncology conferences, important publications and clinical trials. Please send any recommendations to


Multimed Inc.
Publisher of Current Oncology


Volume 19, Number 5 (October 2012)

The latest issue of Current Oncology is now available online. Please visit the following link to view full text articles from this issue:


Upcoming in Current Oncology

The future table of contents for Current Oncology, Volume 19, Number 6 (December 2012) is now available. For the most up-to-date listing of scheduled papers, please visit the following link:

Watch for the upcoming Supplement in 2012!

Prostate Cancer: A Canadian Perspective

Guest Editor, Dr. Fred Saad, is the guest editor of an upcoming supplement to Current Oncology dedicated to prostate cancer. This supplement will cover many of the issues that physicians face on a daily basis when dealing with this disease. Dr. Saad is gathering some of the most respected Canadian authorities to tackle the myriad of important topics that will make up this supplement.


Current Oncology is Seeking Reviewers

Current Oncology is always seeking qualified and dedicated reviewers to assist with the manuscript review process.

Why become a Reviewer?

• Play an integral part in ensuring the high standards of the journal are met
• Provide insight for our authors and help them strengthen their work
• Stay on top of the most up-to-date research
• Gain valuable experience in scientific publishing

Visit to register as a Reviewer today.

Current Oncology Welcomes New Members to our Editorial Team

We are pleased to welcome our newest section editors to our editorial team:
• Dr. Natasha Leighl, Toronto, ON (Section Editor, Medical Economics)
• Dr. Nicole Mittmann, Toronto, ON (Section Editor, Medical Economics)


Have you had the chance to view these Current Oncology “Most-Read” articles?

Most Read Articles in PubMed Central (September 2012)

Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations
Melosky B, Burkes R, Rayson D, Alcindor T, Shear N, Lacouture M
Curr Oncol. 2009 Jan;16(1):16-26

A primer of bone metastases management in breast cancer patients
Petrut B, Trinkaus M, Simmons C, Clemons M
Curr Oncol. 2008 Jan;15(Suppl 1):S50-7

Management of arthralgias associated with aromatase inhibitor therapy
Thorne C
Curr Oncol. 2007 Dec;14 Suppl 1:S11-9

Most Read Recently* Published Articles at

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma
Sherman M, Burak K, Maroun J, Metrakos P, Knox JJ, Myers RP, Guindi M, Porter G, Kachura JR, Rasuli P, Gill S, Ghali P, Chaudhury P, Siddiqui J, Valenti D, Weiss A, Wong R
Curr Oncol. 2011 Oct; 18(5): 228–240

Survivorship services for adult cancer populations: a pan-Canadian guideline
Cancer Journey Survivorship Expert Panel, Howell D, Hack TF, Oliver TK, Chulak T, Mayo S, Aubin M, Chasen M, Earle CC, Friedman AJ, Green E, Jones GW, Jones JM, Parkinson M, Payeur N, Sabiston CM, Sinclair S
Curr Oncol. 2011 Dec;18(6):e265-81

Advances in the management of metastatic breast cancer: options beyond first-line chemotherapy
Ayoub JP, Verma Sh, Verma S
Curr Oncol. 2012 Apr;19(2):91-105

*Published within past 12 months


Register Now!

November 30, 2012 - Toronto, ON, Westin Prince Hotel
February 22, 2013 – Vancouver BC, TBD

The meeting is accredited for 6.5 CME credits.


Contact Us